Glaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024.
- Revenue
- +58.0%
- EPS
- +110.7%
- Free cash flow
- +411.2%
- Total debt
- −2.25%
Quarter to September 2026, against a year earlier
Follow GKOS
Alert me
Glaukos Corporation (GKOS) Gross margin
Glaukos Corporation's gross margin over the twelve months to 30 September 2026 was 81.1%, up 3.2 percentage points from fiscal 2025 (78.0%). Over the past ten years it has ranged from 59.2% (fiscal 2020) to 86.8% (fiscal 2017); the current reading is higher than 55% of that period. That is above the Medical Devices industry median of 57.8% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 78.0% | 2.49 |
| FY2024 | 75.5% | (0.51) |
| FY2023 | 76.0% | 0.38 |
| FY2022 | 75.6% | (1.73) |
| FY2021 | 77.3% | 18.11 |
| FY2020 | 59.2% | (24.49) |
| FY2019 | 83.7% | (2.45) |
| FY2018 | 86.2% | (0.61) |
| FY2017 | 86.8% | 0.92 |
| FY2016 | 85.9% | 3.97 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 85.2% | 3.56 |
| Jun 2026 | 81.7% | 3.81 |
| Mar 2026 | 77.9% | 0.06 |
| Dec 2025 | 77.8% | (0.61) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation | 81.1% |
| PODD Insulet Corporation compare | 71.9% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.7% |
| GMED Globus Medical, Inc. compare | 69.1% |
| PEN Penumbra, Inc. compare | 68.0% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 51.3% |
| BIO Bio-Rad Laboratories, Inc. compare | 51.3% |
| BRKR Bruker Corporation compare | 47.7% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on GKOS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement